U.S. Markets closed

Sunesis (SNSS) Catches Eye: Stock Soars 18.3%

Zacks Equity Research

Sunesis Pharmaceuticals, Inc. (SNSS) was a big mover last session with its shares surging over 18% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend as the stock lost over 12% between Jan 17 and Feb 6.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t remained in trend either. Friday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.

Sunesis currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked biomedical stocks include Actelion Ltd. (ALIOF), Gentium S.p.A (GENT) and Cambrex Corp. (CBM). All these stocks bear a Zacks Rank #1 (Strong Buy).  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>



SUNESIS PHARMACEUTICALS INC NEW (SNSS): Free Stock Analysis Report

ACTELION LTD (ALIOF): Free Stock Analysis Report

GENTIUM SPA GENTIUM SPA ADS ADSS (GENT): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report


Zacks Investment Research